StockData
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) income statement

SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.75−0.00 (-0.32%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Scinai Immunotherapeutics Ltd. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
-202.3%
Operating margin
-575.3%
Net margin
-633.6%
Return on equity, FY2025
-91.9%

Financial strength

Current ratio
1.56
Debt to equity
–
Debt to assets
–
Cash to current liabilities
118.9%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?